ARCHIVE
ID Number: FT-22-3073



This research is provided for historical perspective;
portions of this document may not reflect current conditions.






Oracle's Bid for PeopleSoft: Update 24 February 2004
24 February 2004
 
Jeff Comport   Betsy Burton   Lee Geishecker   Yvonne Genovese  

With its tender offer for PeopleSoft, Oracle is attempting to gain more control over broader markets. Gartner advises how this offer could affect you.









Browse Topics


Other Options







Contact Gartner






Download Document:

PDF

oracles_bid_for...pdf (44.9KB)

Help with Downloads




News Analysis




Event

As of 24 February 2004, the latest developments in Oracle's unsolicited bid to acquire PeopleSoft include:

  • On 23 February 2004, PeopleSoft sent proxy materials to shareholders and recommended that they vote for its own slate of candidates for the board of directors. PeopleSoft's shareholders will vote on the new directors at the annual shareholders meeting on 25 March 2004.
  • On 17 February 2004, Oracle sent out proxy materials urging PeopleSoft shareholders to tender their shares to Oracle, to vote to expand PeopleSoft's board to nine members and to approve the five candidates whom Oracle nominated for it.
  • On 11 February 2004, Oracle and PeopleSoft confirmed they were notified by the U.S. Department of Justice that its lawyers have recommended blocking the Oracle deal on antitrust grounds. The Justice Department will consider this recommendation before issuing its final decision, likely by early March 2004.
  • On 9 February 2004, PeopleSoft's board of directors voted unanimously to recommend that shareholders reject Oracle's latest tender offer.
  • On 4 February 2004, Oracle announced that it has raised its offer for PeopleSoft from $19.50 per share to $26 per share (a total of $9.4 billion in cash). The offer represents about a 19 percent premium over the closing price of PeopleSoft shares on 3 February ($22). Oracle also extended its tender offer to 12 March 2004.



Analysis

Although the Justice Department now seems likely to try to block the deal, it still must take definitive action. Oracle would need to overcome any unfavorable ruling through appeal, negotiation or litigation. In such a case, Oracle would have to decide whether to continue pursuing the acquisition or publicly retreat. A similar antitrust ruling is pending from the European Commission.

The recommendation by PeopleSoft's board to reject Oracle's higher offer price should surprise no one. And it does not alter the nature of the contest. The size and timing of the revised bid indicate that Oracle has begun a final attempt to overcome opposition to the deal in the PeopleSoft camp. According to Oracle, it timed the bid ahead of the 10 February registration deadline for PeopleSoft shareholders who wish to vote their shares at the 25 March stockholders' meeting. Oracle hopes to make PeopleSoft shareholders more receptive to its bid so that they will vote for the slate of board candidates proposed by Oracle. Oracle hopes a new board might remove the "poison pill" provision in the PeopleSoft shareholder agreement, which prevents a hostile takeover, and reconsider the deal. The revised offer and the recommendation of PeopleSoft's board do not affect the Justice Department's inquiry into the deal.

Advice to Clients

Until the Justice Department rules on this case, Gartner continues to advise clients considering PeopleSoft and J.D. Edwards offerings to use Gartner's decision frameworks to determine their strategy. The frameworks yield different advice, depending on a combination of risk tolerance, your opinion on the outcome of Oracle's bid and you company's position in the application life cycle (see "Updated Advice for PeopleSoft Enterprise Clients" and "Updated Advice for PeopleSoft EnterpriseOne Clients"). To develop an opinion on the potential effects of Oracle's bid, consider all the elements that could affect the outcome of this action (see "Pivotal Factors Affecting Oracle's Bid for PeopleSoft").

For Further Information and Research

Gartner continues to work on research related to the individual markets affected and the impact on customers of other vendors. We encourage clients to review our current research, and if you have specific questions, talk with your Gartner analyst — by phone (United States +1 203 316 1266, Europe +44 1784 267770) or e-mail (bizapps@gartner.com, euro.inquiry@gartner.com). Gartner offers the following research:









Browse Topics:
 





© 2004 Gartner, Inc. and/or its Affiliates. All Rights Reserved. Reproduction and distribution of this publication in any form without prior written permission is forbidden. The conclusions, projections and recommendations represent Gartner's initial analysis. As a result, our positions are subject to refinements or major changes as Gartner analysts gather more information and perform further analysis. Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner's research may discuss legal issues related to the information technology business, Gartner does not provide legal advice or services and its research should not be construed or used as such. Gartner shall have no liability for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The opinions expressed herein are subject to change without notice.




Resource Id: 425721